Top

Published in:

07-10-2022 | Parkinson's Disease | Original Article

Fracture risk in Parkinson’s disease according to its severity and duration

Authors: Hye Yeon Koo, Eun Bin Cho, Sung Hye Kong, Kyungdo Han, Kyu Na Lee, Jung Eun Yoo, Ju-Hong Min, Sohyun Chun, Dong Wook Shin

Published in: Osteoporosis International | Issue 1/2023

Abstract

Summary

Fracture risk was elevated in Parkinson’s disease (PD) patients compared with controls in this nationwide study. Among PD patients, the risk of fracture increased linearly with PD severity, whereas no difference in fracture risk was observed according to PD duration.

Introduction

Parkinson’s disease (PD) is reported to be associated with a high risk of fractures. Several studies found an association between severity and duration of PD and falls or bone mineral density, but those factors have not been considered in most previous research. The aim of this study was to determine the fracture risk in PD patients according to their disease severity and duration.

Methods

This population-based, retrospective cohort study used data from the Korean National Health Insurance Service database. The study population included 10,333 patients with prevalent PD and 6,501,464 comparison cohort. Fracture risks according to the prevalence, severity, and duration of PD were evaluated using Cox proportional hazard methods.

Results

Fracture risk was elevated in PD patients at all sites compared with controls (adjusted hazard ratio [aHR] 1.49, 95% confidence interval [CI] 1.44–1.56 for any fracture). When comparing fracture sites, hip fractures showed the largest risk increase in PD patients (aHR 2.16, 95% CI 1.95–2.38). Among PD patients, the risk of any fracture increased linearly with PD severity and was highest in patients with severe disease (aHR 1.65, 95% CI 1.53–1.79 compared with controls). Meanwhile, no significant association was observed between PD duration and fracture risk.

Conclusions

The prevalence of PD was related to an increased risk of fractures in this nationwide study, and PD severity was linearly associated with fracture risk. PD prevalence and severity should be considered when evaluating the risk factors of fracture in clinical practice.

Available only for authorised users

Tysnes O-B, Storstein A (2017) Epidemiology of Parkinson’s disease. J Neural Transm 124(8):901–905CrossRef

Ou Z et al (2021) Global trends in the incidence, prevalence, and years lived with disability of Parkinson’s disease in 204 countries/territories from 1990 to 2019. Front Public Health 9:776847

Pickering RM et al (2007) A meta-analysis of six prospective studies of falling in Parkinson’s disease. Mov Disord 22(13):1892–1900CrossRef

Fink HA et al (2005) Association between Parkinson’s disease and low bone density and falls in older men: the osteoporotic fractures in men study. J Am Geriatr Soc 53(9):1559–1564CrossRef

Sattin RW (1992) Falls among older persons: a public health perspective. Annu Rev Public Health 13(1):489–508CrossRef

Unnanuntana A et al (2010) The assessment of fracture risk The Journal of bone and joint surgery. American vol 92(3):743–753

Liu B et al (2021) Bone mineral density and related scores in Parkinson’s disease: a systematic review and meta-analysis. World Neurosurg 146:e1202–e1218CrossRef

Taggart H, Crawford V (1995) Reduced bone density of the hip in elderly patients with Parkinson’s disease. Age Ageing 24(4):326–328CrossRef

Chen Y-Y et al (2012) Parkinson’s disease and risk of hip fracture: an 8-year follow-up study in Taiwan. Parkinsonism Relat Disord 18(5):506–509CrossRef

10.

Fink HA et al (2008) Association of Parkinson’s disease with accelerated bone loss, fractures and mortality in older men: the Osteoporotic Fractures in Men (MrOS) study. Osteoporos Int 19(9):1277–1282CrossRef

11.

Genever RW, Downes TW, Medcalf P (2005) Fracture rates in Parkinson’s disease compared with age- and gender-matched controls: a retrospective cohort study. Age Ageing 34(1):21–24CrossRef

12.

Gregson CL et al (2014) Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study. Osteoporos Int 25(1):85–95CrossRef

13.

Huang YF et al (2015) Risk and adverse outcomes of fractures in patients with Parkinson’s disease: two nationwide studies. Osteoporos Int 26(6):1723–1732CrossRef

14.

Kalilani L et al (2016) Comparing the incidence of falls/fractures in Parkinson’s disease patients in the US population. PLoS ONE 11(9):e0161689CrossRef

15.

Melton LJ 3rd et al (2006) Fracture risk after the diagnosis of Parkinson’s disease: influence of concomitant dementia. Mov Disord 21(9):1361–1367CrossRef

16.

Pouwels S et al (2013) Risk of fracture in patients with Parkinson’s disease. Osteoporos Int 24(8):2283–2290CrossRef

17.

Schini M et al (2020) The risk of hip and non-vertebral fractures in patients with Parkinson’s disease and parkinsonism: a systematic review and meta-analysis. Bone 132:115173CrossRef

18.

Center JR et al (1999) Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet 353(9156):878–882CrossRef

19.

Keene GS, Parker MJ, Pryor GA (1993) Mortality and morbidity after hip fractures. BMJ 307(6914):1248–1250CrossRef

20.

Bloem BR et al (2001) Prospective assessment of falls in Parkinson’s disease. J Neurol 248(11):950–958CrossRef

21.

Sato Y et al (2001) Risk factors for hip fracture among elderly patients with Parkinson’s disease. J Neurol Sci 182(2):89–93CrossRef

22.

Song IU et al (2009) The relationship between low bone mineral density and Parkinson’s disease in a Korean population. J Clin Neurosci 16(6):807–809CrossRef

23.

Wood B, Walker R (2005) Osteoporosis in Parkinson’s disease. Mov Disord 20(12):1636–1640CrossRef

24.

Wood BH et al (2002) Incidence and prediction of falls in Parkinson’s disease: a prospective multidisciplinary study. J Neurol Neurosurg Psychiatry 72(6):721–725CrossRef

25.

Gray P, Hildebrand K (2000) Fall risk factors in Parkinson’s disease. J Neurosci Nurs 32(4):222–228CrossRef

26.

Allen NE, Schwarzel AK, Canning CG (2013) Recurrent falls in Parkinson’s disease: a systematic review. Parkinsons Dis 2013:906274

27.

Kalia LV, Lang AE (2015) Parkinson’s disease. Lancet 386(9996):896–912CrossRef

28.

Rhee SY et al (2020) Association between glycemic status and the risk of Parkinson disease: a nationwide population-based study. Diabetes Care 43(9):2169–2175CrossRef

29.

Ryu HJ et al (2020) Parkinson’s disease and skin cancer risk: a nationwide population-based cohort study in Korea. J Eur Acad Dermatol Venereol 34(12):2775–2780CrossRef

30.

Kleyweg RP, van der Meché FG, Schmitz PI (1991) Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome. Muscle Nerve 14(11):1103–1109CrossRef

31.

Jung HY et al (2007) Development of the Korean version of Modified Barthel Index (K-MBI): multi-center study for subjects with stroke. Ann Rehabil Med 31:283–297

32.

Hoehn MM, Yahr MD (1967) Parkinsonism. Neurology 17(5):427CrossRef

33.

Agarwal DP (2002) Cardioprotective effects of light-moderate consumption of alcohol: a review of putative mechanisms. Alcohol Alcohol 37(5):409–415CrossRef

34.

Nam GE, Park HS (2018) Perspective on diagnostic criteria for obesity and abdominal obesity in Korean adults. J Obes Metab Syndr 27(3):134–142CrossRef

35.

Yoo JE et al (2022) Blood pressure variability and the risk of fracture: a nationwide cohort study. J Clin Endocrinol Metab 107(4):e1488–e1500

36.

Farahmand BY et al (2000) Socioeconomic status, marital status and hip fracture risk: a population-based case-control study. Osteoporos Int 11(9):803–808CrossRef

37.

Kelsey JL, Samelson EJ (2009) Variation in risk factors for fractures at different sites. Curr Osteoporos Rep 7(4):127–133CrossRef

38.

Wei TS et al (2001) Fall characterictics, functional mobility and bone mineral density as risk factors of hip fracture in the community-dwelling ambulatory elderly. Osteoporos Int 12(12):1050–1055CrossRef

39.

Gao H et al (2015) Lower bone mineral density in patients with Parkinson’s disease: a cross-sectional study from Chinese mainland. Front Aging Neurosci 7:203CrossRef

40.

Bezza A et al (2008) Prevalence and risk factors of osteoporosis in patients with Parkinson’s disease. Rheumatol Int 28(12):1205–1209CrossRef

41.

Nakajima H et al (2021) Clinical and imaging features of surgically treated low lumbar osteoporotic vertebral collapse in patients with Parkinson’s disease. Sci Rep 11(1):14235CrossRef

42.

Cheng KY et al (2014) Factors associated with fall-related fractures in Parkinson’s disease. Parkinsonism Relat Disord 20(1):88–92CrossRef

43.

Bloem BR, van Vugt JP, Beckley DJ (2001) Postural instability and falls in Parkinson’s disease. Adv Neurol 87:209–223

44.

Wickremaratchi MM, Ben-Shlomo Y, Morris HR (2009) The effect of onset age on the clinical features of Parkinson’s disease. Eur J Neurol 16(4):450–456CrossRef

Title: Fracture risk in Parkinson’s disease according to its severity and duration
Authors: Hye Yeon Koo
Eun Bin Cho
Sung Hye Kong
Kyungdo Han
Kyu Na Lee
Jung Eun Yoo
Ju-Hong Min
Sohyun Chun
Dong Wook Shin
Publication date: 07-10-2022
Publisher: Springer London
Keyword: Parkinson's Disease
Published in: Osteoporosis International / Issue 1/2023
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-022-06562-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Fracture risk in Parkinson’s disease according to its severity and duration

Abstract

Summary

Introduction

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Summary

Introduction

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2023

Frailty, length of stay and cost in hip fracture patients

Tea consumption and the risks of osteoporosis and hip fracture: a population-based longitudinal follow-up study

Prevalent vertebral fractures in patients admitted with acute hip fracture

The need to distinguish intervention thresholds and diagnostic thresholds in the management of osteoporosis

Denosumab and muscle performance

Letter to the editor about the article “Beneficial effects of denosumab on muscle performance in patients with low BMD: a retrospective, propensity score-matched study”